Sunil Chari has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sunil Chari, a promoter of Rossari Biotech, has filed a disclosure with the exchange under Regulation 31(4) of the SEBI Substantial Acquisition of Shares and Takeovers (SAST) Regulations, 2011. This is a routine yearly compliance filing where promoters confirm the status of any encumbrances or pledges on their shares. No specific details about changes in stake, pledge creation, invocation, or release have been mentioned in this filing. It is essentially a standard regulatory submission required annually from promoters and persons in control.
This is a routine compliance filing and is unlikely to have any material impact on the stock price or shareholder interests. Investors should wait for any additional disclosures if there are actual changes to the promoter's shareholding or encumbrance status.